We are live on ! Find out more
LSTA icon

Lisata Therapeutics
LSTA

32 hedge funds and large institutions have $12.9M invested in Lisata Therapeutics in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more capital invested

Capital invested by funds: $3.32M → $12.9M (+$9.56M)

175% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 4

0.05% less ownership

Funds ownership: 0.8% → 0.75% (-0.05%)

4% less call options, than puts

Call options by funds: $2.67M | Put options by funds: $2.79M

3% less funds holding

Funds holding: 33 → 32 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
11
Reduced
4
Closed
7
Calls
$2.67M
Puts
$2.79M
Net Calls
-$115K
Net Calls Change
-$255K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$4.98M
2
BlackRock
BlackRock
New York
+$2.04M
3
SM
Sabby Management
Florida
+$980K
4
Renaissance Technologies
Renaissance Technologies
New York
+$837K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$549K

Top Sellers

Rank Fund Capital Flow
1
AFM
Anson Funds Management
Texas
-$345K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$296K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$109K
4
VF
Virtu Financial
New York
-$75K
5
Citadel Advisors
Citadel Advisors
Florida
-$69.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$5.42M +$4.98M +164,277 +719%
Renaissance Technologies
2
Renaissance Technologies
New York
$2.82M +$837K +27,620 +40%
BlackRock
3
BlackRock
New York
$2M +$2.04M +67,187 +3,341%
SM
4
Sabby Management
Florida
$936K +$980K +32,331 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$614K +$549K +18,107 +584%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$197K +$163K +5,372 +372%
Northern Trust
7
Northern Trust
Illinois
$166K +$139K +4,575 +398%
Morgan Stanley
8
Morgan Stanley
New York
$137K +$120K +3,959 +533%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$119K +$82.7K +2,730 +199%
CIBC Private Wealth Group
10
CIBC Private Wealth Group
Georgia
$107K – – –
Millennium Management
11
Millennium Management
New York
$86K +$89.7K +2,960 New
Citadel Advisors
12
Citadel Advisors
Florida
$83K -$69.7K -2,299 -44%
Charles Schwab
13
Charles Schwab
California
$40K +$41.6K +1,372 New
STA
14
Summit Trail Advisors
New York
$34K – – –
GPFA
15
Game Plan Financial Advisors
Ohio
$29K +$30.3K +1,000 New
Two Sigma Advisers
16
Two Sigma Advisers
New York
$26K -$109K -3,600 -80%
SWM
17
Spire Wealth Management
Virginia
$25K +$26.2K +865 New
Creative Planning
18
Creative Planning
Kansas
$23K – – –
Osaic Holdings
19
Osaic Holdings
Arizona
$10K +$30 +1 +0.3%
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
$3K +$4.03K +133 New
Bank of America
21
Bank of America
North Carolina
$2K – – –
Northwestern Mutual Wealth Management
22
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1K – – –
Wells Fargo
24
Wells Fargo
California
$1K +$455 +15 +214%
CG
25
Cutler Group
California
$1K +$1.21K +40 +148%
1
2

LSTA Hedge Fund Activity: Q1 2021 in Review

32 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Lisata Therapeutics (LSTA) for Q1 2021, worth a combined $12.9M — up 288% from $3.32M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of LSTA and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 11 added.

The largest buyer was Vanguard Group, adding an estimated $4.98M. The largest seller was Anson Funds Management, exiting entirely with an estimated $345K sold.

  • 32 institutional investors held Lisata Therapeutics (LSTA) as of Q1 2021, down from 33 in Q4 2020.
  • Funds reported $12.9M of Lisata Therapeutics stock for Q1 2021, up 288% quarter-over-quarter.
  • 6 funds opened new Lisata Therapeutics positions in Q1 2021 and 7 closed out, a net change of -1 holder.
  • The largest Lisata Therapeutics buyer in Q1 2021 was Vanguard Group, an estimated $4.98M added.
  • The largest Lisata Therapeutics seller in Q1 2021 was Anson Funds Management, an estimated $345K sold.

Based on aggregated 13F filings for Q1 2021.